The CSL Limited (ASX: CSL) share price is in the green on Thursday despite the broader market's struggles.
At the time of writing, shares in the healthcare giant are trading for $272.33, 0.53% higher than their previous close.
Meanwhile, the S&P/ASX 200 Index (ASX: XJO) has tumbled 1.12%, and the All Ordinaries Index (ASX: XAO) has slipped 1.17%.
Let's take a look at what might be helping CSL's stock to dodge today's carnage.
Image source: Getty Images
What's buoying the CSL share price?
The CSL share price is outperforming on Thursday, as is its home sector – the S&P/ASX 200 Health Care Index (ASX: XHJ).
The health care sector has spent much of the day in the green but has just edged into the red by 0.06%.
And CSL isn't the sector's best performer.
It's being beaten by ASX 200 staple Ramsay Health Care Limited (ASX: RHC). The stock is boasting a 0.71% gain right now.
Though, it's not all sunshine for the healthcare sector on Thursday.
The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price is plunging 5.97%, making it one of the worst performers on the ASX 200.
Despite today's gains, the CSL share price is still 8.18% lower than it was at the start of 2022. That's compared to the ASX 200's 7.22% year-to-date slip.
Meanwhile, the healthcare index has plummeted 12.22% this year so far.
